Expression Table for this CRE
| SRX7078886 | PanIN cell lines derived from mouse models of pancreatic cancer: Ptf1a-Cre; KrasG12D; p53f/+ PDA | 189.6 |
| SRX7078888 | IPMN cell lines derived from mouse models of pancreatic cancer: Ptf1a-Cre; KrasG12D; Brg1f/f PDA | 151.8 |
| CNhs10596 | forelimb, embryo E11 | 146.8 |
| CNhs14448 | hepatocytes, sham operation, biol_rep2 | 133.3 |
| SRX7078887 | PanIN cell lines derived from mouse models of pancreatic cancer: Ptf1a-Cre; KrasG12D; p53f/+ PDA | 116.7 |
| CNhs10580 | pancreas, embryo E18 | 115.8 |
| CNhs14299 | macrophage, TB infection, non-stimulated BMDM, without Mtb, 048hr, biol_rep3 | 107.0 |
| CNhs11182 | pancreas, neonate N30 | 105.0 |
| CNhs11197 | thymus, neonate N06 | 102.8 |
| SRX690782 | Mdr2-KO liver female etiology/histology:10% AD, 60% HCC | 98.8 |
| CNhs13691 | EBF KO HPCs induced to T cell, 04hr, biol_rep3 | 95.3 |
| CNhs11192 | intestine, neonate N01 | 94.4 |
| CNhs14548 | J2E erythroblastic leukemia response to erythropoietin, 02hr00min, biol_rep3 | 91.5 |
| CNhs11201 | diencephalon, neonate N30 | 90.9 |
| CNhs10483 | bone (os femoris), adult | 86.1 |
| CNhs14124 | ES-46C derived epistem cells, biol_rep2 | 85.6 |
| SRX10234855 | Lung smooth muscle cells of C57BL/6 strain WT mouse | 83.7 |
| CNhs11209 | heart, neonate N16 | 83.3 |
| CNhs11220 | liver, neonate N20 | 80.3 |
| CNhs13124 | ST2 (Mesenchymal stem cells) cells, differentiation to adipocytes, 36hr, biol_rep1 (036hA1) | 80.1 |
| CNhs10476 | mammary gland, adult pregnant day19 | 79.7 |
| CNhs13259 | ST2 (Mesenchymal stem cells) cells, differentiation to osteocytes, 00hr15min, biol_rep2 (015mB2) | 79.3 |
| CNhs10508 | adrenal gland, adult | 78.0 |
| SRX7078889 | IPMN cell lines derived from mouse models of pancreatic cancer: Ptf1a-Cre; KrasG12D; Brg1f/f PDA | 78.0 |
| CNhs14125 | ES-46C derived epistem cells, biol_rep3 | 77.7 |
| CNhs10472 | placenta, adult pregnant day10 | 77.6 |
| SRX10234854 | Lung smooth muscle cells of C57BL/6 strain WT mouse | 76.3 |
| CNhs14403 | liver sinusoidal endothelial cells, partial hepatectomy, 30hr, biol_rep2 | 75.9 |
| SRX10234857 | Lung smooth muscle cells of C57BL/6 strain TET3 KO mouse | 75.8 |
| DRX055093 | WT 130 min after induced by 5 mM EDTA in PBS rep3 | 75.5 |
| CNhs13267 | ST2 (Mesenchymal stem cells) cells, differentiation to osteocytes, 24hr, biol_rep2 (024hB2) | 75.4 |
| CNhs11492 | macrophage, TB infection, stimulated BMDM+IL-4/IL-13(aaMph), without Mtb, 072hr, biol_rep1 | 74.6 |
| CNhs13297 | ST2 (Mesenchymal stem cells) cells, differentiation to adipocytes, 03hr, biol_rep3 (003hA3) | 74.5 |
| SRX690775 | Mdr2-KO liver female etiology/histology:0% AD, 50% HCC | 73.7 |
| SRX9816723 | nitric oxide unexposed lung tissue of wild type mice | 73.5 |
| SRX9816725 | nitric oxide unexposed lung tissue of wild type mice | 73.4 |
| SRX9816722 | nitric oxide unexposed lung tissue of wild type mice | 72.6 |
| SRX10234856 | Lung smooth muscle cells of C57BL/6 strain TET3 KO mouse | 72.5 |
| SRX8428121 | NR5A1-expressing pre-Sertoli cells in E11.5 gonads of C57BL/6 strain mouse: genotype Nr5a1-hCD271 | 72.5 |
| CNhs10598 | forelimb, embryo E17 | 72.3 |
| SRX690778 | Mdr2-KO liver male etiology/histology:20% AD, 70% HCC | 71.5 |
| SRX690781 | Mdr2-KO liver male etiology/histology:20% AD, 80% HCC | 71.3 |
| CNhs11219 | lung, neonate N10 | 70.9 |
| CNhs11214 | kidney, neonate N00 | 70.7 |
| DRX055089 | WT 120 min after induced by 5 mM EDTA in PBS rep2 | 69.8 |
| CNhs11483 | macrophage, TB infection, stimulated BMDM+IL-13(aaMph), without Mtb, 120hr, biol_rep1 | 69.8 |
| SRX9816729 | nitric oxide unexposed lung tissue of triply n/i/eNOSs-/- mice | 69.6 |
| CNhs11486 | macrophage, TB infection, stimulated BMDM+IL-4/IL-13(aaMph), without Mtb, 006hr, biol_rep1 | 69.5 |
| SRX690779 | Mdr2-KO liver male etiology/histology:20% AD, 70% HCC | 69.4 |
| CNhs11491 | macrophage, TB infection, stimulated BMDM+IL-4/IL-13(aaMph), without Mtb, 048hr, biol_rep1 | 69.3 |